Skip to content

DOCTEUR ABOUD

Active Private limited companyfounded 2023active for 3 yearsRue Gilles-Galler 55, 4000 LiègeKBO/BCE: BE 0802.818.916

Lifetime

3 annual accounts with figures on one time axis
peak of €209,945 in 2025
€209,945▲ 34.3%
peak of €119,746 in 2025
€119,746▲ 24.9%
peak of €176,810 in 2025
€176,810▲ 210%
€211,748▼ 15.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €156,297 to €209,945Equity from €57,065 to €176,810Debts from €250,517 to €211,748Cash from €24,598 to €100,660

Key points

from the 2025 annual accounts

Equity

€176,810 ▲ 210%
€57,1002024€177,0002025

Equity rose in 2025 from €57,065 to €176,810.

Turnover

≈ €380,000 estimated

The micro format states no turnover.

Liquidity

1.69 was 0.40 in 2024

Short-term debts fell from €96,928 to €67,910.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,330 companies had the same profile as DOCTEUR ABOUD has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,330 companies, not a prediction for DOCTEUR ABOUD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 16-06-2023
  • 100 sharesdeed of 20-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0802818916
Incorporation Founding capital of €6,200, 100 shares · Founded by · appointed as director · published on 20-06-2023 · Gazette deed
First establishment Rue de la Boverie 811, Seraing
All 9 events

Comparable companies

same main activity, similar in size and age
Company
DOCTEUR ABOUD Liège €388,559 €209,945 45.5% -
DELAHAUT NUMA Verviers €340,836 €201,011 93.4% -
Lobradoc Lierde €402,053 €219,450 74.5% -
Dr. Heungens Sander, Huisarts Lokeren €384,173 €225,321 72.6% -
DOKTER MICHIEL Destelbergen €379,514 €225,412 85.8% -
Dr. Ilse Janssens Grobbendonk €413,129 €202,387 70.0% -
Chiropraxie Desimpele Waregem €367,963 €201,607 52.8% -

These companies have the same main activity as DOCTEUR ABOUD: general medical practice (NACE 86210). They are comparable in size and age: total assets between €341,000 and €413,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 16-06-2023Normal situation
Activity
General medical practiceNACE 86210
Joint committee
330Health institutions and services · annual accounts 2025
Establishment unit
2.369.583.3064100 Seraing, since 16-06-2023
Financial year end
31 December
Peppol
Reachable since 20-06-2026
Company details

Annual accounts 2025

€388,559▲ 26.3%
Employeeson 31-12-2025
1
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on DOCTEUR ABOUD

DOCTEUR ABOUD files the micro format. That format states no turnover. The gross margin rose from €40,528 in 2023 to €209,945 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOCTEUR ABOUD

What is the company number of DOCTEUR ABOUD?
The company number of DOCTEUR ABOUD is 0802.818.916. The VAT number is the same number with BE in front: BE 0802.818.916.
Where is DOCTEUR ABOUD based?
The registered office is at Rue Gilles-Galler 55, 4000 Liège.Company details
What does DOCTEUR ABOUD do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOCTEUR ABOUD?
DOCTEUR ABOUD is a private limited company (BV).
When was DOCTEUR ABOUD founded?
DOCTEUR ABOUD was founded on 16-06-2023.
Is DOCTEUR ABOUD still active?
Yes, DOCTEUR ABOUD is an active enterprise in the KBO register.
How many employees does DOCTEUR ABOUD have?
DOCTEUR ABOUD had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DOCTEUR ABOUD fall under?
In its 2025 annual accounts, DOCTEUR ABOUD states joint committee 330 (Health institutions and services).
What is the turnover of DOCTEUR ABOUD?
The turnover in financial year 2025 is about €380,000. This figure is estimated from the gross margin of €209,945 and 30 comparable companies (NACE 86210). It probably lies between €300,000 and €480,000.
Is DOCTEUR ABOUD profitable?
In financial year 2025, DOCTEUR ABOUD made a profit of €119,746.
Where can I find the annual accounts of DOCTEUR ABOUD?
DOCTEUR ABOUD filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOCTEUR ABOUD due?
DOCTEUR ABOUD must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.